Free Trial
Notice: This company has been marked as potentially delisted and may not be actively trading.
NASDAQ:GOBI

Gobi Acquisition (GOBI) Stock Price, News & Analysis

About Gobi Acquisition Stock (NASDAQ:GOBI)

Key Stats

Today's Range
$10.00
$10.00
50-Day Range
$9.61
$9.82
52-Week Range
$9.61
$10.05
Volume
259 shs
Average Volume
12,235 shs
Market Capitalization
$258.50 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Gobi Acquisition Corp. is a blank check company. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or related business combination with one or more businesses. Gobi Acquisition Corp. is based in Hong Kong.

Receive GOBI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Gobi Acquisition and its competitors with MarketBeat's FREE daily newsletter.

GOBI Stock News Headlines

Could TSLA reach $500 a share? Free ebook says it’s possible.
Even though shares of Tesla are only up 3% this year, one man believes Tesla’s next bull run is just around the corner. In his professional opinion, the share price could reach $500 or more… Now, we understand that may seem far-fetched, but as you’ll see in his new ebook, it’s not as crazy as it may sound. In fact, he argues a Trump presidency could make it happen much faster than you might think. which is why we’re emailing you now… For the time being, he’s giving away his Tesla ebook for free. Inside explains how shares could reach $500 in the near future.
See More Headlines

GOBI Stock Analysis - Frequently Asked Questions

Gobi Acquisition (GOBI) raised $250 million in an IPO on Tuesday, June 29th 2021. The company issued 25,000,000 shares at a price of $10.00 per share.

Based on aggregate information from My MarketBeat watchlists, some other companies that Gobi Acquisition investors own include Aerovate Therapeutics (AVTE), Aveanna Healthcare (AVAH), Autohome (ATHM), Atai Life Sciences (ATAI), Angel Oak Mortgage REIT (AOMR), Anebulo Pharmaceuticals (ANEB) and Ambrx Biopharma (AMAM).

Company Calendar

Today
11/04/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Industry
Holding & Other Investment Offices
Sub-Industry
N/A
Current Symbol
NASDAQ:GOBI
Web
N/A
Fax
N/A
Employees
2,021
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Book Value
($0.05) per share

Miscellaneous

Free Float
N/A
Market Cap
$258.50 million
Optionable
Not Optionable
Beta
-0.04
2025 Gold Forecast: A Perfect Storm for Demand Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

This page (NASDAQ:GOBI) was last updated on 11/5/2024 by MarketBeat.com Staff
From Our Partners